The heme oxygenase system rescues hepatic deterioration in the condition of obesity co-morbid with type-2 diabetes.

The prevalence of non-alcoholic fatty-liver disease (NAFLD) is increasing globally. NAFLD is a spectrum of related liver diseases that progressive from simple steatosis to serious complications like cirrhosis. The major pathophysiological driving of NAFLD includes elevated hepatic adiposity, increas...

Full description

Bibliographic Details
Main Authors: Tatiana Ntube Salley, Manish Mishra, Shuchita Tiwari, Ashok Jadhav, Joseph Fomusi Ndisang
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2013-01-01
Series:PLoS ONE
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24260182/?tool=EBI
id doaj-c166a91c05ff447c8376536f3176defd
record_format Article
spelling doaj-c166a91c05ff447c8376536f3176defd2021-03-03T20:18:59ZengPublic Library of Science (PLoS)PLoS ONE1932-62032013-01-01811e7927010.1371/journal.pone.0079270The heme oxygenase system rescues hepatic deterioration in the condition of obesity co-morbid with type-2 diabetes.Tatiana Ntube SalleyManish MishraShuchita TiwariAshok JadhavJoseph Fomusi NdisangThe prevalence of non-alcoholic fatty-liver disease (NAFLD) is increasing globally. NAFLD is a spectrum of related liver diseases that progressive from simple steatosis to serious complications like cirrhosis. The major pathophysiological driving of NAFLD includes elevated hepatic adiposity, increased hepatic triglycerides/cholesterol, excessive hepatic inflammation, and hepatocyte ballooning injury is a common histo-pathological denominator. Although heme-oxygenase (HO) is cytoprotective, its effects on hepatocyte ballooning injury have not been reported. We investigated the effects of upregulating HO with hemin or inhibiting it with stannous-mesoporphyrin (SnMP) on hepatocyte ballooning injury, hepatic adiposity and inflammation in Zucker-diabetic-fatty rats (ZDFs), an obese type-2-diabetic model. Hemin administration to ZDFs abated hepatic/plasma triglycerides and cholesterol, and suppressed several pro-inflammatory cytokines and chemokines including, TNF-α, IL-6, IL-1β, macrophage-inflammatory-protein-1α (MIP-1α) and macrophage-chemoattractant-protein-1 (MCP-1), with corresponding reduction of the pro-inflammatory M1-phenotype marker, ED1 and hepatic macrophage infiltration. Correspondingly, hemin concomitantly potentiated the protein expression of several markers of the anti-inflammatory macrophage-M2-phenotype including ED2, IL-10 and CD-206, alongside components of the HO-system including HO-1, HO-activity and cGMP, whereas the HO-inhibitor, SnMP abolished the effects. Furthermore, hemin attenuated liver histo-pathological lesions like hepatocyte ballooning injury and fibrosis, and reduced extracellular-matrix/profibrotic proteins implicated in liver injury such as osteopontin, TGF-β1, fibronectin and collagen-IV. We conclude that hemin restore hepatic morphology by abating hepatic adiposity, suppressing macrophage infiltration, inflammation and fibrosis. The selective enhancement of anti-inflammatory macrophage-M2-phenotype with parallel reduction of pro-inflammatory macrophage-M1-phenotype and related chemokines/cytokines like TNF-α, IL-6, IL-1β, MIP-1α and MCP-1 are among the multifaceted mechanisms by which hemin restore hepatic morphology.https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24260182/?tool=EBI
collection DOAJ
language English
format Article
sources DOAJ
author Tatiana Ntube Salley
Manish Mishra
Shuchita Tiwari
Ashok Jadhav
Joseph Fomusi Ndisang
spellingShingle Tatiana Ntube Salley
Manish Mishra
Shuchita Tiwari
Ashok Jadhav
Joseph Fomusi Ndisang
The heme oxygenase system rescues hepatic deterioration in the condition of obesity co-morbid with type-2 diabetes.
PLoS ONE
author_facet Tatiana Ntube Salley
Manish Mishra
Shuchita Tiwari
Ashok Jadhav
Joseph Fomusi Ndisang
author_sort Tatiana Ntube Salley
title The heme oxygenase system rescues hepatic deterioration in the condition of obesity co-morbid with type-2 diabetes.
title_short The heme oxygenase system rescues hepatic deterioration in the condition of obesity co-morbid with type-2 diabetes.
title_full The heme oxygenase system rescues hepatic deterioration in the condition of obesity co-morbid with type-2 diabetes.
title_fullStr The heme oxygenase system rescues hepatic deterioration in the condition of obesity co-morbid with type-2 diabetes.
title_full_unstemmed The heme oxygenase system rescues hepatic deterioration in the condition of obesity co-morbid with type-2 diabetes.
title_sort heme oxygenase system rescues hepatic deterioration in the condition of obesity co-morbid with type-2 diabetes.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2013-01-01
description The prevalence of non-alcoholic fatty-liver disease (NAFLD) is increasing globally. NAFLD is a spectrum of related liver diseases that progressive from simple steatosis to serious complications like cirrhosis. The major pathophysiological driving of NAFLD includes elevated hepatic adiposity, increased hepatic triglycerides/cholesterol, excessive hepatic inflammation, and hepatocyte ballooning injury is a common histo-pathological denominator. Although heme-oxygenase (HO) is cytoprotective, its effects on hepatocyte ballooning injury have not been reported. We investigated the effects of upregulating HO with hemin or inhibiting it with stannous-mesoporphyrin (SnMP) on hepatocyte ballooning injury, hepatic adiposity and inflammation in Zucker-diabetic-fatty rats (ZDFs), an obese type-2-diabetic model. Hemin administration to ZDFs abated hepatic/plasma triglycerides and cholesterol, and suppressed several pro-inflammatory cytokines and chemokines including, TNF-α, IL-6, IL-1β, macrophage-inflammatory-protein-1α (MIP-1α) and macrophage-chemoattractant-protein-1 (MCP-1), with corresponding reduction of the pro-inflammatory M1-phenotype marker, ED1 and hepatic macrophage infiltration. Correspondingly, hemin concomitantly potentiated the protein expression of several markers of the anti-inflammatory macrophage-M2-phenotype including ED2, IL-10 and CD-206, alongside components of the HO-system including HO-1, HO-activity and cGMP, whereas the HO-inhibitor, SnMP abolished the effects. Furthermore, hemin attenuated liver histo-pathological lesions like hepatocyte ballooning injury and fibrosis, and reduced extracellular-matrix/profibrotic proteins implicated in liver injury such as osteopontin, TGF-β1, fibronectin and collagen-IV. We conclude that hemin restore hepatic morphology by abating hepatic adiposity, suppressing macrophage infiltration, inflammation and fibrosis. The selective enhancement of anti-inflammatory macrophage-M2-phenotype with parallel reduction of pro-inflammatory macrophage-M1-phenotype and related chemokines/cytokines like TNF-α, IL-6, IL-1β, MIP-1α and MCP-1 are among the multifaceted mechanisms by which hemin restore hepatic morphology.
url https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24260182/?tool=EBI
work_keys_str_mv AT tatianantubesalley thehemeoxygenasesystemrescueshepaticdeteriorationintheconditionofobesitycomorbidwithtype2diabetes
AT manishmishra thehemeoxygenasesystemrescueshepaticdeteriorationintheconditionofobesitycomorbidwithtype2diabetes
AT shuchitatiwari thehemeoxygenasesystemrescueshepaticdeteriorationintheconditionofobesitycomorbidwithtype2diabetes
AT ashokjadhav thehemeoxygenasesystemrescueshepaticdeteriorationintheconditionofobesitycomorbidwithtype2diabetes
AT josephfomusindisang thehemeoxygenasesystemrescueshepaticdeteriorationintheconditionofobesitycomorbidwithtype2diabetes
AT tatianantubesalley hemeoxygenasesystemrescueshepaticdeteriorationintheconditionofobesitycomorbidwithtype2diabetes
AT manishmishra hemeoxygenasesystemrescueshepaticdeteriorationintheconditionofobesitycomorbidwithtype2diabetes
AT shuchitatiwari hemeoxygenasesystemrescueshepaticdeteriorationintheconditionofobesitycomorbidwithtype2diabetes
AT ashokjadhav hemeoxygenasesystemrescueshepaticdeteriorationintheconditionofobesitycomorbidwithtype2diabetes
AT josephfomusindisang hemeoxygenasesystemrescueshepaticdeteriorationintheconditionofobesitycomorbidwithtype2diabetes
_version_ 1714823029855354880